Friday, August 26, 2016

Blood Cancer Journal - Table of Contents alert Volume 6 August 2016

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 6, August 2016

In this issue
Original Articles
Letters to the Editor
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement
Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article.

Original Articles

Top

Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts

M Cartellieri, A Feldmann, S Koristka, C Arndt, S Loff, A Ehninger, M von Bonin, E P Bejestani, G Ehninger and M P Bachmann

Blood Cancer J 2016 6: e458; 10.1038/bcj.2016.61

Abstract | Full Text

Pim2 is important for regulating DNA damage response in multiple myeloma cells

J Ramachandran, L Santo, K T Siu, C Panaroni and N Raje

Blood Cancer J 2016 6: e462; 10.1038/bcj.2016.73

Abstract | Full Text

A population-based study of large granular lymphocyte leukemia

M V Shah, C C Hook, T G Call and R S Go

Blood Cancer J 2016 6: e455; 10.1038/bcj.2016.59

Abstract | Full Text

Letters to the Editor

Top

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib

M K Angelopoulou, J V Asimakopoulos, Z Galani, G Levidou, M Roumelioti, T P Vassilakopoulos, P Korkolopoulou and P Panayiotidis

Blood Cancer J 2016 6: e461; 10.1038/bcj.2016.66

Full Text

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing

A Angona, C Fernández-Rodríguez, A Alvarez-Larrán, L Camacho, R Longarón, E Torres, S Pairet, C Besses and B Bellosillo

Blood Cancer J 2016 6: e463; 10.1038/bcj.2016.75

Full Text

Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene

A Hayashi, R Tanoshima, S-I Tsujimoto, M Yanagimachi, M Takeuchi, K Sasaki, J Ikeda, R Kajiwara, S Ito and H Takahashi

Blood Cancer J 2016 6: e456; 10.1038/bcj.2016.52

Full Text

Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma

L He, H-Y Zhu, S-C Qin, Y Li, Y Miao, J-H Liang, Y Xia, Y Wang, Y-J Wu, L Wang, L Fan, J-Y Li and W Xu

Blood Cancer J 2016 6: e457; 10.1038/bcj.2016.67

Full Text

Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells

A T Stefka, J-H Park, Y Matsuo, S Chung, Y Nakamura, A J Jakubowiak and S Rosebeck

Blood Cancer J 2016 6: e460; 10.1038/bcj.2016.71

Full Text

Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera

I S Tiong, D A Casolari, T Nguyen, M J M Van Velzen, K Ambler, R J D'Andrea and D M Ross

Blood Cancer J 2016 6: e459; 10.1038/bcj.2016.70

Full Text

Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients

G R A de Mendonça, A B C Brito, R M Rocha, M T Delamain, R de Andrade Natal, F A Soares, G W B Colleoni, C A Souza, J Vassallo and C S P Lima

Blood Cancer J 2016 6: e464; 10.1038/bcj.2016.76

Full Text

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: